Cargando…

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial

(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 heal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyawaki, Masahiro, Sano, Hiroyuki, Imbe, Hisashi, Fujisawa, Reiko, Tanimoto, Keiji, Terasaki, Jungo, Maeda-Yamamoto, Mari, Tachibana, Hirofumi, Hanafusa, Toshiaki, Imagawa, Akihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073342/ https://www.ncbi.nlm.nih.gov/pubmed/30029523 http://dx.doi.org/10.3390/nu10070924

Ejemplares similares

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Decreased β-Cell Function Is Associated with Reduced Skeletal Muscle Mass in Japanese Subjects without Diabetes
por: Sakai, Satoshi, et al.
Publicado: (2016)

Randomized controlled trial of the effects of consumption of ‘Yabukita’ or ‘Benifuuki’ encapsulated tea-powder on low-density lipoprotein cholesterol level and body weight
por: Igarashi, Yuko, et al.
Publicado: (2017)

Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes
por: Haseda, Fumitaka, et al.
Publicado: (2016)

Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel α-Cell Model of Insulin-Deficient Diabetes
por: Bessho, Megumi, et al.
Publicado: (2014)

Association between Functional Capacity Decline and Nutritional Status Based on the Nutrition Screening Initiative Checklist: A 2-Year Cohort Study of Japanese Community-Dwelling Elderly
por: Sugiura, Yumiko, et al.
Publicado: (2016)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies
por: Tsutsumi, Chiharu, et al.
Publicado: (2011)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
por: Kawasaki, Eiji, et al.
Publicado: (2008)

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
por: Murase-Mishiba, Yuko, et al.
Publicado: (2008)

Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma‐associated antigen‐2 autoantibodies in the identification and characterization of Japanese type 1 diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma‐associated antigen‐2 and zinc transporter 8
por: Kawasaki, Eiji, et al.
Publicado: (2020)

Pancreatic β‐cells express major histocompatibility complex class II: Do diabetic β‐cells have the capacity of antigen‐presenting cells?
por: Sano, Hiroyuki, et al.
Publicado: (2019)

Research following genome‐wide association study focuses on the multifaceted nature of Src kinase‐associated phosphoprotein 2 in type 1 diabetes
por: Sano, Hiroyuki, et al.
Publicado: (2022)

Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
por: Sano, Hiroyuki, et al.
Publicado: (2022)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy
por: Tanimizu, Hikaru, et al.
Publicado: (2023)

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
por: Magistroni, Riccardo, et al.
Publicado: (2013)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Association of Apolipoprotein E in Lipoprotein Subspecies With Risk of Dementia
por: Koch, Manja, et al.
Publicado: (2020)

Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
por: Li, Yan-hong, et al.
Publicado: (2014)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Méndez-Lara, Karen Alejandra, et al.
Publicado: (2020)

Interactions of Apolipoprotein A-I with High-Density Lipoprotein Particles
por: Nguyen, David, et al.
Publicado: (2013)

The specific core fucose-binding lectin Pholiota squarrosa lectin (PhoSL) inhibits hepatitis B virus infection in vitro
por: Ouchida, Tsunenori, et al.
Publicado: (2023)

Association between angiopoietin-like protein 2 and lectin-like oxidized low-density lipoprotein receptor 1 ligand containing apolipoprotein B in patients with type 2 diabetes
por: Suzuki, Tatsuhiko, et al.
Publicado: (2018)

Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
por: Clark, Justin R., et al.
Publicado: (2022)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

Type 1 Diabetes and Interferon Therapy: A nationwide survey in Japan
por: Nakamura, Kan, et al.
Publicado: (2011)

Birth Weight, Cord Blood Lipoprotein and Apolipoprotein Levels in Indian Newborns
por: Kharb, Simmi, et al.
Publicado: (2010)

Apolipoprotein(a) is the Product of a Pseudogene: Implications for the Pathophysiology of Lipoprotein(a)
por: Sloop, Gregory D, et al.
Publicado: (2018)

Reference Materials for the Standardization of the Apolipoproteins A-I and B, and Lipoprotein(a)
por: Dati, Francesco, et al.
Publicado: (2001)

Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
por: Almer, Gunter, et al.
Publicado: (2015)

Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults
por: Haslam, Danielle E, et al.
Publicado: (2022)

Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins
Publicado: (1977)

Transport of Apolipoprotein B-Containing Lipoproteins through Endothelial Cells Is Associated with Apolipoprotein E-Carrying HDL-Like Particle Formation
por: Yang, Hong, et al.
Publicado: (2018)

Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins in vitro
por: Yan, Ying, et al.
Publicado: (2019)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_jek1ch5ta2qdrot2mmhmqmeo47